Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Verastem, Inc. (VSTM)

Verastem prices stock offering of 30.9 million shares at $8.00 for about $234.7 million

Neutral Impact 3 of 5 financing Written later

Verastem agreed to sell 30,937,500 common shares at $8.00 each, plus pre-funded warrants for up to 312,503 shares, through underwriters led by Jefferies and Guggenheim. The company expects net proceeds of about $234.7 million, with closing expected on or about October 15, 2026. The sale adds a substantial number of shares to the outstanding count, which dilutes existing holders.

Key points

  • 30,937,500 common shares offered at $8.00 each, before underwriting discounts and commissions
  • Pre-funded warrants for up to 312,503 shares offered at $7.9999 each, with a $0.0001 exercise price
  • Expected net proceeds of approximately $234.7 million, after underwriting discounts and estimated expenses
  • Offering made under a shelf registration effective August 15, 2025; closing expected on or about October 15, 2026

The filing

CompanyVerastem, Inc. (VSTM)
Form8-K, current report
Filed with the SECOct 14, 2026, 5:21 PM ET
Accession number0001104659-26-115880

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.